Institutional Ownership
Allarity Therapeutics Inc
CUSIP 016744500COMALLRQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
12
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Nov 13, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 13, 2024 | 3i, LP | 13G/A | — | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Renaissance Technologies LLC | 228.1K | $248.6K |
| 2 | Geode Capital Management, LLC | 190.4K | $207.5K |
| 3 | State Street Corp | 137.6K | $150.0K |
| 4 | Northern Trust Corp | 48.1K | $52.4K |
| 5 | Xtx Topco Ltd | 29.0K | $31.6K |
| 6 | Two Sigma Investments, LP | 27.5K | $30.0K |
| 7 | Ubs Group AG | 23.2K | $25.2K |
| 8 | Two Sigma Securities, LLC | 12.3K | $13.4K |
| 9 | Citigroup Inc | 7.8K | $8.5K |
| 10 | Danske Bank A/S | 1 | $1 |